Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

A prospective study of corticosteroid and catecholamine levels in relation to viral respiratory illness.

Mason JW, Buescher EL, Belfer ML, Artenstein MS, Mougey EH.

J Human Stress. 1979 Sep;5(3):18-28.

PMID:
225383
3.

Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans.

Zollinger WD, Mandrell RE, Altieri P, Berman S, Lowenthal J, Artenstein MS.

J Infect Dis. 1978 Jun;137(6):728-39.

PMID:
77885
4.
5.
6.

The ecology of the genus Neisseria.

Griffiss JM, Artenstein MS.

Mt Sinai J Med. 1976 Nov-Dec;43(6):746-61. No abstract available.

PMID:
827689
7.

Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens.

Zollinger WD, Dalrymple JM, Artenstein MS.

J Immunol. 1976 Nov;117(5 Pt.2):1788-98.

PMID:
825573
8.

Use of diagnostic microbiologic facilities in the diagnosis of head and neck infections.

Carpenter JL, Artenstein MS.

Otolaryngol Clin North Am. 1976 Oct;9(3):611-29. No abstract available.

PMID:
988529
9.

Clinical correlation of strain differentiation of Neisseria gonorrhoeae.

Tramont EC, Griffiss JM, Rose D, Brooks GF, Artenstein MS.

J Infect Dis. 1976 Aug;134(2):128-34.

PMID:
823271
10.

Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A.

Plaut AG, Gilbert JV, Artenstein MS, Capra JD.

Science. 1975 Dec 12;190(4219):1103-5.

PMID:
810892
11.

Control of meningococcal meningitis with meningococcal vaccines.

Artenstein MS.

Yale J Biol Med. 1975 Jul;48(3):197-200. Review.

12.

Immunologic hyporesponsiveness in man to group C meningococcal polysaccharide.

Artenstein MS, Brandt BL.

J Immunol. 1975 Jul;115(1):5-7.

PMID:
807629
13.

Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide.

Brandt BL, Artenstein MS.

J Infect Dis. 1975 May;131 Suppl:S69-72.

PMID:
805191
14.

Prophylaxis for meningococcal disease.

Artenstein MS.

JAMA. 1975 Mar 10;231(10):1035-7. No abstract available.

PMID:
803581
15.

Coxsackievirus B5 infection and aseptic meningitis in neonates and children.

Marier R, Rodriguez W, Chloupek RJ, Brandt CD, Kim HW, Baltimore RS, Parker CL, Artenstein MS.

Am J Dis Child. 1975 Mar;129(3):321-5.

PMID:
1121962
16.
17.
18.

The outer cell-wall membrane of Pseudomonas aeruginosa.

Sadoff JC, Artenstein MS.

J Infect Dis. 1974 Nov;130 Suppl(0):S81-93. No abstract available.

PMID:
4214235
19.

Clinical and epidemiological correlates of Pseudomonas typing.

Baltimore RS, Dobek AS, Stark FR, Artenstein MS.

J Infect Dis. 1974 Nov;130 Suppl(0):S53-9. No abstract available.

PMID:
4213951
20.

Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction.

Tramont EC, Sadoff JC, Artenstein MS.

J Infect Dis. 1974 Sep;130(3):240-7. No abstract available.

PMID:
4213017
21.

Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient.

Stark FR, Thornsvard C, Flannery EP, Artenstein MS.

N Engl J Med. 1974 Aug 1;291(5):239-40. No abstract available.

PMID:
4525537
22.

Recurrent meningococcal infection with an antigenically identical strain.

Griffiss JM, Bannatyne RM, Artenstein MS, Anglin CS.

JAMA. 1974 Jul 1;229(1):68-70. No abstract available.

PMID:
4134964
23.
24.

Adult meningoencephalitis caused by herpesvirus hominis type 2.

Morrison RE, Miller MH, Lyon LW, Griffiss JM, Artenstein MS.

Am J Med. 1974 Apr;56(4):540-4. No abstract available.

PMID:
4361958
25.

Immunoprophylaxis of meningococcal infection.

Artenstein MS, Winter PE, Gold R, Smith CD.

Mil Med. 1974 Feb;139(2):91-5. No abstract available.

PMID:
4204814
26.

Immunodiagnosis and immunization in bacterial meningitis.

Artenstein MS.

Adv Neurol. 1974;6:161-7. No abstract available.

PMID:
4141219
27.

Antibody responses to meningococcal polysaccharide vaccines.

Brandt BL, Artenstein MS, Smith CD.

Infect Immun. 1973 Oct;8(4):590-6.

28.

Response of children to Neisseria meningitidis polysaccharide vaccines.

Monto AS, Brandt BL, Artenstein MS.

J Infect Dis. 1973 Apr;127(4):394-400. No abstract available.

PMID:
4632878
29.

Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.

Kasper DL, Winkelhake JL, Brandt BL, Artenstein MS.

J Infect Dis. 1973 Apr;127(4):378-87. No abstract available.

PMID:
4121052
30.

Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.

Kasper DL, Winkelhake JL, Zollinger WD, Brandt BL, Artenstein MS.

J Immunol. 1973 Jan;110(1):262-8. No abstract available.

PMID:
4346607
31.

Mutation of gonococci and meningococci in vitro to rifampin (rifampicin) resistance.

Schneider H, Dobek AS, Artenstein MS.

Br J Vener Dis. 1972 Dec;48(6):500-3. No abstract available.

32.

Isolation and characterization of a native cell wall complex from Neisseria meningitidis.

Zollinger WD, Kasper DL, Veltri BJ, Artenstein MS.

Infect Immun. 1972 Nov;6(5):835-51.

33.

Immunologic response of man to group B meningococcal polysaccharide vaccines.

Wyle FA, Artenstein MS, Brandt BL, Tramont EC, Kasper DL, Altieri PL, Berman SL, Lowenthal JP.

J Infect Dis. 1972 Nov;126(5):514-21. No abstract available.

PMID:
4197754
34.

Meningococcal infections.

Artenstein MS.

N Engl J Med. 1972 Oct 19;287(16):825-6. No abstract available.

PMID:
5057562
35.

A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody.

Brandt BL, Wyle FA, Artenstein MS.

J Immunol. 1972 Apr;108(4):913-20. No abstract available.

PMID:
4623401
36.
37.

Hemagglutination inhibition for serogrouping of Neisseria meningitidis.

Cohen RL, Artenstein MS.

Appl Microbiol. 1972 Feb;23(2):289-92.

38.

Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping.

Gold R, Winklehake JL, Mars RS, Artenstein MS.

J Infect Dis. 1971 Dec;124(6):593-7. No abstract available.

PMID:
5001751
39.

Serologic studies of meningococcal infection and polysaccharide vaccination.

Artenstein MS, Brandt BL, Tramont EC, Branche WC Jr, Fleet HD, Cohen RL.

J Infect Dis. 1971 Sep;124(3):277-88. No abstract available.

PMID:
4947187
40.
41.

Meningococcal infections. 3. Studies of group A polysaccharide vaccines.

Artenstein MS, Branche WC Jr, Zimmerly JG, Cohen RL, Tramont EC, Kasper DL, Harkins C.

Bull World Health Organ. 1971;45(3):283-6.

42.
43.

Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964-70.

Artenstein MS, Schneider H, Tingley MD.

Bull World Health Organ. 1971;45(3):275-8.

44.
45.

Current status of prophylaxis of meningococcal disease.

Artenstein MS, Gold R.

Mil Med. 1970 Sep;135(9):735-9. No abstract available.

PMID:
4991223
46.

Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man.

Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Branche WC Jr, Harkins C.

J Infect Dis. 1970 Apr;121(4):372-7. No abstract available.

PMID:
4985950
47.

Prevention of meningococcal disease by group C polysaccharide vaccine.

Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H, Harkins C.

N Engl J Med. 1970 Feb 19;282(8):417-20. No abstract available.

PMID:
4983754
48.

Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections.

Bellanti JA, Artenstein MS, Brandt BL, Klutinis BS, Buescher EL.

J Immunol. 1969 Nov;103(5):891-8. No abstract available.

PMID:
4187116
49.

Chemoprophylaxis of meningococcal carriers.

Artenstein MS.

N Engl J Med. 1969 Sep 18;281(12):678. No abstract available.

PMID:
4980026
50.

Supplemental Content

Loading ...
Support Center